A. Morice (Cottingham, United Kingdom), V. Macbean (London, United Kingdom), P. Paggiaro (Pisa, Italy), A. Bikov (Miskolc, Hungary)
LATE-BREAKING ABSTRACT: A useful physiological marker for evaluating the effect of indacaterol in COPD patients.
Y. Okada, Y. Kono, S. Soeda, H. Hara, K. Araki, M. To, Y. To (Tokyo, Koshigaya, Japan)
|   |
Activities during the World Asthma Day in 2012: Its utility for detecting underdiagnosis and undertreatment in asthma patients
S. E. Marquez, A. L. Echazarreta, M. O. Macuso, E. Maniago, A. R. Manti (La Plata, Gonnet La Plata, Argentina)
| |
Asthma severity and diagnostic assessment in subjects older than 40 years in a 12-months cohort of patients referred to a tertiary asthma clinic
C. Porsbjerg, A. Sverrild, V. Backer (Copenhagen, Denmark)
| |
Measuring health-related quality of life (HRQL) in adults with controlled or partially controlled asthma
M. Vieira, E. Pizzichini, C. Rocha, M. Pizzichini (Florianópolis, Brazil)
| |
Asthma control is reached in a large majority of asthmatics treated with omalizumab. An Italian observational study
F. Novelli, G. Lenzini, M. Latorre, L. Malagrinò, F. L. Dente, P. L. Paggiaro (Pisa, Italy)
| |
Are ACQ scores a useful measure of severity in obese patients?
S. Zaidi, C. Higgs, J. Lee, E. Ukeleghe, I. Benton, J. Finnerty, A. Ponnuswamy, S. Scott (Chester, United Kingdom)
| |
Control and drug attitude during the first trimester of pregnancy in asthmatic women
E. Martinez Moragon, B. Antequera, T. Bazus, A. Romero, R. Ana, D. D. Alfredo, G. R. J. Luis (Valencia, Port Sagunt, Oviedo, Sevilla, Madrid, Laredo, Spain)
| |
Influence of body mass index on asthma severity and control: A cross-sectional study
S. Osanai, T. Ogasa (Asahikawa, Japan)
| |
Impact of obesity on markers of asthma severity, control, health-related quality of life (HrQOL) and eosinophilia
M. Murthy, I. Karpha, R. Yadavilli, D. Lees, H. Burhan (Liverpool, United Kingdom)
| |
Assessing the impact of body mass index on FEV1% and quality of life in asthma patients
S. Jain, A. Golmohamed (Liverpool, United Kingdom)
| |
Impact of anxiety and depression in asthma control
A. Tiotiu, C. Clément-Duchêne, P. Vaillant, D. Tiotiu, Y. Martinet (Nancy, France)
| |
Cough hypersentivity syndrome: Preliminary findings of the ERS taskforce
A. Morice, K. F. Chung, P. Dicpinigaitis, L. McGarvey, E. Millqvist, R. Sakalauskas, K. Stravinskaite, A. Pacheco, S. Birring, J. Smith, M. Belvisi, L. Dupont, A. Kantar, R. Del Negro (Cottingham, London, Belfast, Manchester, United Kingdom; The Bronx, London, United States Of America; Gothenburg, Sweden; Kaunas, Lithuania; Madrid, Spain; Leuven, Belgium; Misurina-B, Bussolengo, Italy)
| |
Chronic obstructive pulmonary disease: How good is GOLD on its own?!
M. Rajabi, M. Sharbafi, H. Moezzi, M. Shamssian (Tehran, Islamic Republic Of Iran; Ajman, United Arab Emirates; North Stafforidshire, United Kingdom)
| |
Justification for statistical process control in daily home spirometry for COPD patients
W. Sirichana, M. H. Patel, M. S. Taylor, C. H. Tseng, I. Barjaktarevic, E. C. Kleerup, C. B. Cooper (Los Angeles, Philadelphia, United States Of America; Bangkok, Thailand)
| |
Validity and reliability of Turkish version of St. George's respiratory questionnaire
M. Polatli, A. Yorgancioglu, O. Aydemir, N. Y. Demirci, G. Kirkil, S. A. Nayci, N. Kokturk, A. Uysal, G. Gunakan (Aydin, Manisa, Ankara, Elazig, Mersin, Istanbul, Turkey)
| |
COPD screening and risk factor frequency identification study
S. Ashraf, M. Zaman (Peshawar, Pakistan)
| |
Correlation of nutritional status using subjective global assessment (SGA) on pulmonary function parameters in patients with COPD at the Philippine Heart Center
C. Alea, M. P. Mateo (Quezon City, Philippines)
| |
Psychosomatic disorders in patients with COPD
O. Semendyayeva, N. Monogarova, D. Stupachenko, V. Khandildy, V. Valutsina (Donetsk, Ukraine)
| |
Development of a standardized sputum colour chart based on the natural colour system
S. Abbeel, P. Goeminne, D. Ruttens, L. Dupont (Leuven, Belgium)
| |